MedPath

effect of vitamin D on glycated hemoglobin A1 in patients with uncontrolled type 2 diabetes with vitamin D deficiency.

Phase 2
Conditions
Type 2 diabetes.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2013072414143N1
Lead Sponsor
For research ,kermanshah university of medical science vice chancellor
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

Patients who are receiving vitamin D supplement or who received it in late or have chronic liver disease or chronic renal failure(GFR<30ml/min)or have diseases related vitamin D or have malabsorption remote from study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglubin A1c. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.
Secondary Outcome Measures
NameTimeMethod
Fasting plasma glucose. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;Triglyceride. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;Total cholestrol. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;High density cholestrol. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;Low density cholestrol. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.
© Copyright 2025. All Rights Reserved by MedPath